10017 — New York, New York

10017 is a clinical research site located in New York, New York, United States 10017.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

10017 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Breast Cancer.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 10017?

10017 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 10017 conducted?

10017 has 1 clinical trials on record. Their work covers Metastatic Breast Cancer.

Is 10017 accredited by Crixeo Health?

10017 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 10017?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.